As the market is making new highs, some analysts predict that the S&P 500 is due for a pullback at 1200 range. Whether this is true or not the market seems to be in an uptrend with Dow Jones rising above 12,100 and NASDAQ reaching 2800. The fact that some companies are even increasing their dividends and the inflow of mergers and acquisitions by midsized companies goes to show that the recovery is starting to pick up speed.

Following are some of the stocks that are making headlines today that are considered microcap, so without further ado let's dive right in. Ampal American (NASDAQ: AMPL) recently announced that it has been advised by the East Mediterranean gas, in which the company has a 12.6% interest, was not damaged by the recent explosion of a gas metering station in Egypt. Because of this the supply gas to EMG, and therefore to EMG's immediate Israeli clients has been interrupted by a fire in a facility not related to EMG. Reuters stated that the gas supply to the EMG should resume operations within a week.

To our surprise the stock has been rallying 5.45% at Monday's open with a 21,085 shares volume which is fairly moderate compared to the three month average volume of 27,223. The stock has been trading in the last 52 weeks between $1.39 up to three dollars even. I would definitely keep an eye out on this stock especially within the next week to see if there is gas supply operations resume within the given time table.

Ampal-American Israel Corporation (Ampal) primarily acquires interests in businesses located in the State of Israel or that are Israel-related. The Company's investment focus is principally on companies or ventures where Ampal can exercise significant influence, on its own or with investment partners, and can use its management experience to enhance those investments. It focuses to invest in undervalued assets with an emphasis in sectors, such as: Energy, Chemicals, Telecommunications, Real Estate, Project Development and Leisure Time.

Our next company is Crystallex (AMEX:KRY) that recently it received a letter from the corporation Venezolana de Guayana then stated that the company's mine operating contract for the loss of Christina's project in Bolivar state Venezuela, has been unilaterally terminated by the CVG. The letter also enclosed a copy of a resolution passed by the CVG on February 3, 2011 which also stated that the MOC is unilaterally terminated.

Investors and traders of course have viewed this news as a pessimistic outcome as the shares of the stock KRY has tumbled 37% at the market open with an astounding volume of 10.6 million shares. The stock has already been in a downtrend for the past seven months as a 52-week range and zigzag around $.13 up to $.77

Crystallex international Corporation normally engages in the development of gold properties in Venezuela. It has principally owned interest in the last Christina's gold project that is located in Sifontes Municipality in Bolivar State Venezuela. the company was founded back in 1984 and is headquartered in Toronto Canada.

EpiCept (NASDAQ: EPCT) has been under a tremendous pressure to keep it stuck price per share above one dollar in the last few months. it today announced positive results coming from the phase 2B trial evaluating the efficacy and safety of the attic NP1chemo that chemo therapy induced peripheral neuropathy. The results of the trial with the intent to treat population demonstrated that the change in average daily new Europe passing intensity scores in the and P1 group has achieved a statistically significant reduction in CPN intensity versus placebo which was the trial's primary endpoint in addition the prespecified subgroup of the ITT population those patients who previously received tax saying chemotherapy also have shown a statistically significant reduction in average daily Europe passing intensity scores this subgroup constitute more than 50% of the ITT population.

Because of this stocks have rallied almost 16% of the market open with a volume of three times the average at 666,000 hundred and 24 shares traded so far. Another $.13 and the company can meet NASDAQ's minimum requirements to sustain its listing on the exchange. For the past two weeks the company has traded between $.33 and $2.45 a share.

EpiCept Corp. normally focuses on the development and commercialization of pharmaceutical products for the treatment of cancer and pain in the United States and Germany one of its main products that has had quite a success is the Ceplene, which was used for the treatment of acute myeloid leukemia.

Another company that is in play today is Inovio Pharmaceuticals (AMEX: INO). the company has gone up 1.55% of the market opens with a volume of 243,887 shares traded by midday. It recently announced that its new generation DNA vaccine delivery technology, which provides the powerful enabling capabilities of LA troll proration without contacting the skin. implementing this new technology can also provide other desirable benefits. By eliminating the insertion of needles used in the conventional electroporation process and reducing the electrical pulsing 2 ns makes this contact contactless device even more tolerable than current electroporation devices.

This companyhas a market capitalization of $135.5 million and has been trading between $.76 and $1.56 in the past 52-week range and has a target of one year estimate of $2.96. The company does not pay dividends at this time.

The company is engaged in the discovery development and delivery of DNA vaccines with a focus on cancers and other infectious diseases. It's the Syncon technology enables the design of DNA-based vaccines are capable of providing cross protection against unmatched strains of pathogens such as influenza.

Almaden Minerals (AMEX: AAU) today announced that to drill explorations and definition programs are now underway at the company's wholly owned Ixtaca gold and silver project located in Puebla state, Mexico. The company's goals for the year 2011 at Almaden is to outline the potential of the Ixtaca zone by a minimum CAD to million drill program. In addition the company states that the drilling in 2011 is designed to explore the size potential of the Ixtaca Zone.

Almaden Minerals Limited, is considered to be an exploration stage company that engages in the acquisition exploration and development of mineral properties in Canada as well as the United States and Mexico. It holds interests in the elk gold and silver property compromising the Siwash gold deposits in Canada and the Caballo Blanco gold in Mexico.

BullsEyeMicrocaps.com is not a registered investment advisers or broker/dealer. BullsEyeMicrocaps.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: BullsEyeMicrocaps.com has not been compensated for any stocks listed in this stock news report.

Valence Technology, Inc. (NASDAQ: VLNC) has recently reported a loss of $0.01 per share, that was better than the Thomson Reuters consensus of $0.02). Company's revenues rose 236.6% a year to $13.8 million versus the $13.7 million consensus. Valence Technolgoy also issued in-line guidance for Q4, sees Q4 revenues of $13-15 million vs. $15.04 million Thomson Reuters consensus.

You have got to keep an eye out on this stock as it's trending in a smooth uptrend on its 50-day moving average with an RSI that is not overbought or oversold. If you draw a horizontal line form its higher lows, you would have an easier time identifying entry and exit points.

Valence Technology, Inc. develops, manufactures and sells dynamic energy systems utilizing its phosphate-based lithium-ion technology. The Company engaged in the development of lithium iron magnesium phosphate dynamic energy storage systems. In November 2009, the Company introduced a Revision 2 of its U-Charge Lithium Phosphate Energy Storage Systems. In addition to the U-Charge family of products, the Company offers the materials, cells and systems. The Company operates in five markets: motive, stationary, industrial, military and marine.

Almaden Minerals Ltd. (AMEX: AAU) Company reported its 2011 objectives, goals and budgets for the exploration drilling program at Ixtaca as well as other drilling projects that the company will embark on throughout the year. They have significant amount of cash and they are prepared to use it to drill several other projects that they have 100% ownership on. Stock has gained a moderate 1% so far with a volume of 78,451 shares traded at the open. Don't jump on this one with both feet, but definitely keep it on a watch and a close eye on its volume, making sure it's not a bear trap. Company has a phenomenal balance sheet with plenty of equity and low debt, it's worth the risk.

Almaden Minerals Ltd. is an exploration-stage company. Almaden is engaged in the business of the acquisition, exploration and when warranted, development of mineral properties. The Company has property interests in Canada, United States and Mexico. The Company has two primary property interests: the Elk gold, silver property, which includes the Siwash Gold deposit in Canada and the Caballo Blanco gold, silver, copper prospect in Mexico The Company's secondary property interests include the ATW diamond prospect in Canada, the Merit prospect in Canada, the San Carlos prospect in Mexico and the Yago prospect in Mexico.

DARA BioSciences, Inc. (NASDAQ: DARA) Company announces Phase II drug candidate is getting attention, just as planned. "Big phrama is interested in us... We started the process of putting KRN5500 out there as an out-license candidate. We have a number of companies, right now, doing deep due diligence. We have a virtual due diligence room. There are companies both big and medium sized, both international and domestic that are looking at KRN5500 right now." was stated by management.

DARA is showing increased activity once more. Stock has popped 2.15% so far to settle at $3.88 with an increased volume of 327,188 shares. It built a strong support on the $3.85 level and has been consolidating with slight bullish tendencies of spiking time to time to $4.00.

DARA BioSciences, Inc. is a development-stage pharmaceutical company that acquires therapeutic drug candidates for development and licensing or sale to healthcare companies. The Company focuses its therapeutic development efforts on small molecules from late preclinical development through Phase II clinical trials.

DayStar Technologies, Inc. (NASDAQ: DSTI) Company recently announced it has entered into a $5 million securities purchase agreement with Socius Capital Group. Company also announced the additional extinguishment of debt in exchange for shares of common stock as the company continues to restructure its balance sheet and pursue a strategic partnership. DSTI also announced that it has paid off additional $3.6 mln in debt from its balance sheet through the conversion to equity of certain convertible notes payable

I personally like stocks that have been beaten down over time, and are now in a consolidation mode. DSTI is toggling with its 50-day moving average of $1.57. Stock took a loss of 0.63% so far with a light volume of 25,800 to settle at $1.58

DayStar Technologies, Inc. has developed a thin film deposition technology for solar photovoltaic (PV) products. The Company utilizes a one-step sputter deposition process and has manufactured a commercial scale deposition tool to apply high-efficiency copper indium gallium diselenide (CIGS) material over large area glass substrates in a continuous fashion.

Eastman Kodak (NYSE: EK) This company has really been in the shambles ever since the digital era of photography came into picture. At its strategy meeting today with investors, company will detail plans to complete its transformation into a digital company with sustainable profits by 2012. Between 2011 and 2013, the company expects revenue from these businesses to more than double, with annuity sales, from ink and consumables, growing as a percentage of revenue. In 2013, co expects revenue from these businesses will approach $2.0 bln, with positive earnings.

This stock has lost more than 30% of its value in a recent drop from $5.40 to $3.61 with a surging volume. It dropped another 1.5% today as the RSI went below 25 oversold level. I might consider playing this stock for a quick 1% or 2% in the next few days. This is a short seller's heaven as the 200-day moving average dropped below its 50-day moving avereage. Keep an eye out on this one.

Eastman Kodak Company is engaged in the sale of imaging products, technology, solutions and services to consumers, businesses and professionals. The Company's products span digital still and video cameras and related accessories; consumer inkjet printers and media; digital picture frames; retail printing kiosks, APEX drylab systems and related media; KODAK Gallery online imaging services; prepress equipment and consumables; workflow software for commercial printing; electro-photographic equipment and consumables; commercial inkjet printing systems; document scanners; photographic paper and processing chemicals

BullseyeMicrocaps.com is not a registered investment advisers or broker/dealer. BullseyeMicrocaps.com makes no recommendation that the purchase of securities of companies profiled in this website is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. Always do you own homework before investing in any stock.

Forward-Looking Statement: This press release includes "forward-looking statements" within the meaning of the federal securities laws, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Although the Company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Important factors that could cause actual results to differ materially from the Company's projections and expectations are disclosed in the Company's filings with the Securities and Exchange Commission. All forward-looking statements in this press release are expressly qualified by such cautionary statements and by reference to the underlying assumptions.

Disclosure: BullseyeMicrocaps.com has not been compensated for any stocks listed in this stock news report